中医药治疗肺结核临床疗效及对肺功能的影响研究进展
张掖市第二人民医院
肺结核是慢性呼吸道传染疾病中最常见的病症,主要是因结核分枝杆菌感染所致,分枝杆菌会引发肺部结核病,累及肝、肾、脑、淋巴结等其他器官,最终导致患者患上肺外结核病,直接影响到患者的健康以及日常生活质量。在临床常规治疗方案中,主要通过指导患者使用抗结核类药物进行治疗,对患者体内结核病菌进行抑制,达到帮助患者恢复健康的目的。但结合临床观察可知,在常规西医治疗的过程中需要面临患者出现耐药性以及长期用药治疗过程中不良反应的问题。为避免在治疗中出现各种不良反应,引入中医治疗的方式为肺结核治疗提供了新思路,从中医层面对患者进行治疗,在帮助患者各方面症状进行改善的同时可以有效降低肺结核患者治疗期间不良反应发生率,促进患者受损肺功能的恢复,综合保障患者的治疗效果。因此从中医层面对肺结核患者进行治疗逐步被临床所重视。本次分析旨在探讨中医药治疗肺结核患者的临床疗效以及患者肺功能的改善效果。
Pulmonary tuberculosis is the most common disease in chronic respiratory infectious diseases, which is mainly caused by the infection of mycobacterium tuberculosis. Mycobacterium can cause pulmonary tuberculosis, involving the liver, kidney, brain, lymph nodes and other organs, and eventually causing patients to form extrapulmonary tuberculosis, which will directly affect patients' health and daily life. In the routine clinical treatment plan, the patient is mainly guided to use anti tuberculosis drugs for treatment, and the tuberculosis bacillus in the patient's body is suppressed to help the patient recover. However, based on clinical observations, it is known that in the process of conventional western medicine treatment, there are issues of drug resistance and adverse reactions during long-term medication treatment. To avoid various adverse reactions during treatment, the introduction of traditional Chinese medicine treatment provides a new approach for the treatment of tuberculosis. Treating patients from the perspective of traditional Chinese medicine can help improve their symptoms in all aspects while effectively reducing the incidence of adverse reactions during the treatment of tuberculosis patients, promoting the recovery of damaged lung function, and comprehensively ensuring the treatment effect on patients. Therefore, the treatment of tuberculosis patients from the perspective of traditional Chinese medicine has gradually been valued by clinical practice. This analysis aims to explore the clinical efficacy of traditional Chinese medicine in treating patients with pulmonary tuberculosis, as well as the improvement effect on the lung function of these patients.
引用本文
按标准格式复制,或导出到文献管理软件参考文献
共 20 条- [1]唐苗苗,曹培谦,王志刚.益气补肺汤加减联合西药治疗肺结核气阴两虚证疗效观察及对TNFSF14、sIL-2R水平的影响[J].新中医,2025,57(22):28-33.
- [2]夏苏英,刘艳科.浅论《十药神书》治疗肺痨的临床思路[J].中华中医药杂志,2011,26(11):21-22.
- [3]王晨曦,黎维,张军.基于《黄帝内经》“肝咳”理论探讨从肝论治感染后咳嗽[J].湖南中医杂志,2025,41(8):117-120.
- [4]孔思琪,李金田,梁建庆,等.“金水相生”视域下《金匮要略》中肺系疾病的辨治思路研究[J].天津中医药,2024,41(10):1251-1255.
- [5]沈翊康,姜婧,张钰欣,等.《中藏经》肝脏辨证理论研究[J].中国中医药现代远程教育,2022,20(20):68-70.
- [6]曹东东.肺结核的中医治疗[J].健康必读,2025,(23):121.
- [7]刘嵋松,孙良梅,王胜圣.中西医结合疗法治疗初治继发性肺结核病的临床疗效及安全性评价[J].中国中医药信息杂志,2013,20(9):51-53.
- [8]黄晋,潘静洁,刘堂营.中医药治疗初治肺结核的研究近况[J].智慧健康,2023,9(3):69-73.
- [9]杨莹,黄雪惠,彭湘汕.利福平注射液和参麦注射液治疗肺结核的近期效果观察[J].中国热带医学,2015,23(8):31.
- [10]徐红艳.参麦注射液对肺结核患者血清β-CAR,IL-17及CD4+细胞表达的影响[J].世界中医药,2018,13(1):51-52.
- [11]郑鑫蕊.痰热清联合抗生素治疗肺结核并发感染的临床价值[J].中国现代药物应用,2023,17(11):117-119.
- [12]Huang Q,Li K,Li Q. Effect of Traditional Chinese Medicine on antituberculosis drug therapy for pulmonary tuberculosis and liver function.[J]. Journal of infection in developing countries,2025,19(4):504-511.
- [13]钱旭武,蒋婴,张冉,等.浅论《医学心悟》药对运用[J].中医药信息,2012,23(3):120-121.
- [14]韩章琴,崔栋.月华丸加减汤剂联合HRZE药物对肺结核患者痰菌转阴率及血清T淋巴细胞亚群水平的影响[J].医学理论与实践,2024,37(7):1132-1134.
- [15]周建伟,周秩权,张锦.加味补阳还五汤治疗气阴两虚兼瘀血痹阻型肺结核65例[J].湖南中医杂志,2025,41(5):13-16.
- [16]余心琦,陈道挺,童三香.养阴利肺汤联合HRZE方案对肺结核患者肺功能、炎性因子和免疫功能的影响[J].中国中医药科技,2025,32(3):462-464.
- [17]白延璐,张阔,张宇,等.基于网络药理学和分子对接技术探究百合固金汤在肺结核治疗中的作用[J].解剖科学进展,2024,30(6):593-598.
- [18]李继翰,国美峰,倪磊磊,等.百合固金汤联合利奈唑胺对耐多药肺结核患者肺功能及T淋巴细胞亚群的影响[J].天津中医药,2025,42(4):431-435.
- [19]曹亚伟,周保仓,王存丽,等.补肺活血胶囊联合抗痨药物治疗肺结核疗效观察[J].辽宁中医杂志,2023,50(9):138-141.
- [20]廉桃梅,陈瑛,崔晓华,等.补肺活血胶囊联合2HRZE/4HR方案治疗初治老年肺结核的临床观察及对外周血细胞亚群的影响[J].中草药,2025,23(17):11-14.
| 文章编号 | 2026-05-002(期号内编号) |
|---|---|
| 栏目 | 综述 |
| 作者 | 王锋栋 |
| 作者单位 | 张掖市第二人民医院 |
| 中图分类号 | R259 |
| 卷期页码 | 2026, 2(05): 5-8 |
| 发布时间 | 2026-08-15 |
| 出版时间 | 2026-08-15 |
| 引用信息 | [1]王锋栋.中医药治疗肺结核临床疗效及对肺功能的影响研究进展[J].疾病预防与控制,2026,2(05):5-8. |
| 全文地址 | 在知网查看该文(kns.cnki.net) |
| 数据抓取时间 | 2026-09-22T12:07:21 |